Simcere Pharmaceutical Group. Earnings: What Investors Should Watch

Simcere Pharmaceutical Group. (NYSE:SCR) will report earnings before markets open on Thursday, May 9th. Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company’s products include antibiotics, anti-cancer medications and anti-stroke medications.

Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.11 to a profit $0.12. For the current year, the average estimate is a profit of $0.39, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Simcere Pharmaceutical Group. has been performing on an annual basis: